BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/27/2018 8:15:15 AM | Browse: 964 | Download: 1266
 |
Received |
|
2017-10-29 01:25 |
|
Peer-Review Started |
|
2017-10-29 04:58 |
|
To Make the First Decision |
|
2017-11-28 08:16 |
|
Return for Revision |
|
2017-11-28 09:53 |
|
Revised |
|
2017-12-28 15:38 |
|
Second Decision |
|
2018-01-24 08:20 |
|
Accepted by Journal Editor-in-Chief |
|
2018-01-24 08:39 |
|
Accepted by Company Editor-in-Chief |
|
2018-01-29 18:16 |
|
Articles in Press |
|
2018-01-29 18:16 |
 |
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-03-18 13:06 |
|
Publish the Manuscript Online |
|
2018-03-27 08:15 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected byan in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Metabolomics: From liver chiromancy to personalized precision medicine in advanced chronic liver disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Bogdan Procopet, Petra Fischer, Oana Farcau and Horia Stefanescu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| UEFISCDI, Romania |
PN-II-RU-TE-2014-4-0709 |
| UEFISCDI, Romania |
PN-II-RU-TE-2014-4-0356 |
|
| Corresponding Author |
Horia Stefanescu, MD, MSc, PhD, Doctor, Staff Physician, Hepatology Unit, Regional Institute of Gastroenterology and Hepatology, str Croitorilor nr 19-21, Cluj 400162, Cluj, Romania. horia.stefanescu@irgh.ro |
| Key Words |
Metabolomics; Biomarker; Prediction; Advanced chronic liver disease; Decompensation; Alcoholic hepatitis; Hepatocellular carcinoma |
| Core Tip |
Currently there is a lack of accurate biomarkers for diagnosis and prognosis in advanced liver diseases. Either the occurrence of first decompensation, or diagnosis of acute on chronic liver failure, severe alcoholic hepatitis, or hepatocellular carcinoma (HCC), none of the available biomarkers are satisfactory. This review proposes a synthesis of the existing evidences of metabolomics use in advanced chronic liver diseases, decompensated liver cirrhosis, severe alcoholic hepatitis and HCC. |
| Publish Date |
2018-03-27 08:15 |
| Citation |
Procopet B, Fischer P, Farcau O, Stefanescu H. Metabolomics: From liver chiromancy to personalized precision medicine in advanced chronic liver disease. World J Hepatol 2018; 10(3): 371-378 |
| URL |
http://www.wjgnet.com/1948-5182/full/v10/i3/371.htm |
| DOI |
http://dx.doi.org/10.4254/wjh.v10.i3.371 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
